HEALTH SCIENCE
Health Education —
The 2nd China-Jilin Pharmaceutical and Healthcare Industry Development Forum – Chemical Drug Forum, September 8, 2014
Release date:
2020-08-07
On September 7, 2013, the "2nd China·Jilin Pharmaceutical and Health Industry Development Forum—Chemical Drug Forum," jointly hosted by the China Biotechnology Development Center and the Jilin Provincial Department of Science and Technology, and organized by the Jilin Provincial Biopharmaceutical Industry Promotion Group Office and the Jilin Provincial Modern Traditional Chinese Medicine and Biopharmaceutical Base Construction Promotion Association, with co-organization from Jilin Bodaweiye Pharmaceutical Co., Ltd., was grandly held in Changchun. Zhang Weihan, Deputy Director of the Jilin Provincial Department of Science and Technology, attended the forum and delivered a speech. Leaders from the provincial science and technology department, representatives from member units of the provincial pharmaceutical industry promotion group, as well as officials responsible for pharmaceutical industry promotion or science and technology management from relevant cities (prefectures), counties (cities, districts), and over 200 participants—including leaders and R&D personnel from universities, research institutions, and pharmaceutical companies across the province—joined the event. The forum was chaired by Duan Chengjun, Chairman of Bodaweiye Pharmaceutical. This year’s forum focused primarily on the innovative development of new chemical drugs. Ding Jian, Director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and an Academician of the Chinese Academy of Engineering, delivered the keynote speech. Additionally, five renowned experts presented at specialized forums: Du Guanhua, Researcher at the Drug Screening Center of Peking Union Medical College; Dr. Zhang Yongxiang, Deputy Minister/Researcher at the Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences; Dr. Zhang Yonghe, Deputy Director of the Peking University Sleep Medicine Center and Associate Director of the Department of Pharmacology at the School of Basic Medical Sciences; and Dr. Liu Jianxun, Chief Researcher at the China Academy of Chinese Medical Sciences and a leading expert in Chinese medicine and pharmacology in China.
|
On September 7, 2013, the "2nd China·Jilin Pharmaceutical and Health Industry Development Forum—Chemical Drug Forum," jointly hosted by the China Biotechnology Development Center and the Jilin Provincial Department of Science and Technology, and organized by the Jilin Provincial Biopharmaceutical Industry Promotion Group Office and the Jilin Provincial Modern Chinese Medicine and Biopharmaceutical Base Construction Promotion Association, with co-organization from Jilin Boda Weiye Pharmaceutical Co., Ltd., was grandly held in Changchun. Zhang Weihan, Deputy Director of the Jilin Provincial Department of Science and Technology, attended the forum and delivered a speech. Leaders from the provincial science and technology department, representatives from member units of the provincial pharmaceutical industry promotion group, as well as officials responsible for pharmaceutical industry promotion or science and technology management from relevant cities (prefectures), counties (cities, districts), and more than 200 participants—including leaders and R&D personnel from universities, research institutions, and pharmaceutical companies across the province—joined the event. The meeting was chaired by Duan Chengjun, Chairman of Boda Weiye Pharmaceutical. This forum focuses primarily on the innovative development of chemical drugs. Ding Jian, Director of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and an academician of the Chinese Academy of Engineering, delivered a keynote speech at the event. Additionally, five distinguished experts presented their insights during the special forum, including Researcher Du Guanhua from the Drug Screening Center of Peking Union Medical College; Dr. Zhang Yongxiang, Deputy Director-General/Researcher at the Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences; Dr. Zhang Yonghe, Deputy Director of the Peking University Sleep Medicine Center and Deputy Director of the Department of Pharmacology at the School of Basic Medical Sciences; and Dr. Liu Jianxun, Chief Researcher at the China Academy of Chinese Medical Sciences and a leading expert in Chinese medicine and pharmacology in China.
|
Keywords:
Previous page:
